{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:56:12Z","timestamp":1790621772291,"version":"4.1.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T00:00:00Z","timestamp":1668556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T00:00:00Z","timestamp":1668556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"HHMI and US National Institutes of Health award","award":["RM1 HG009490"],"award-info":[{"award-number":["RM1 HG009490"]}]},{"name":"Confidence in Collaboration in Advanced Therapies Award","award":["TS14352"],"award-info":[{"award-number":["TS14352"]}]},{"name":"CureEB Charity","award":["RE18567"],"award-info":[{"award-number":["RE18567"]}]},{"name":"EB Research Partnership","award":["RE17721"],"award-info":[{"award-number":["RE17721"]}]},{"DOI":"10.13039\/100002077","name":"EB Medical Research Foundation","doi-asserted-by":"crossref","award":["RE17763"],"award-info":[{"award-number":["RE17763"]}],"id":[{"id":"10.13039\/100002077","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Base editing introduces precise single-nucleotide edits in genomic DNA and has the potential to treat genetic diseases such as the blistering skin disease recessive dystrophic epidermolysis bullosa (RDEB), which is characterized by mutations in the\n                    <jats:italic>COL7A1<\/jats:italic>\n                    gene and type VII collagen (C7) deficiency. Adenine base editors (ABEs) convert A-T base pairs to G-C base pairs without requiring double-stranded DNA breaks or donor DNA templates. Here, we use ABE8e, a recently evolved ABE, to correct primary RDEB patient fibroblasts harboring the recurrent RDEB nonsense mutation c.5047 C\u2009&gt;\u2009T (p.Arg1683Ter) in exon 54 of\n                    <jats:italic>COL7A1<\/jats:italic>\n                    and use a next generation sequencing workflow to interrogate post-treatment outcomes. Electroporation of ABE8e mRNA into a bulk population of RDEB patient fibroblasts resulted in remarkably efficient (94.6%) correction of the pathogenic allele, restoring\n                    <jats:italic>COL7A1<\/jats:italic>\n                    mRNA and expression of C7 protein in western blots and in 3D skin constructs. Off-target DNA analysis did not detect off-target editing in treated patient-derived fibroblasts and there was no detectable increase in A-to-I changes in the RNA. Taken together, we have established a highly efficient pipeline for gene correction in primary fibroblasts with a favorable safety profile. This work lays a foundation for developing therapies for RDEB patients using ex vivo or in vivo base editing strategies.\n                  <\/jats:p>","DOI":"10.1038\/s41598-022-24184-8","type":"journal-article","created":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T06:05:57Z","timestamp":1668578757000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["ABE8e adenine base editor precisely and efficiently corrects a recurrent COL7A1 nonsense mutation"],"prefix":"10.1038","volume":"12","author":[{"given":"Adam","family":"Sheriff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ina","family":"Guri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Zebrowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Llopis-Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imogen R.","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavroula","family":"Tekkela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavita","family":"Subramaniam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruta","family":"Gebrezgabher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Naso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Petrova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Balon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandros","family":"Onoufriadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Kujawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martyna","family":"Kotulska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Newby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0141ukasz","family":"\u0141aczma\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"McGrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Jack\u00f3w","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,16]]},"reference":[{"key":"24184_CR1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.5582\/irdr.2017.01005","volume":"6","author":"E Rashidghamat","year":"2017","unstructured":"Rashidghamat, E. & McGrath, J. A. Novel and emerging therapies in the treatment of recessive dystrophic epidermolysis bullosa. Intractable Rare Dis. Res. 6, 6\u201320. https:\/\/doi.org\/10.5582\/irdr.2017.01005 (2017).","journal-title":"Intractable Rare Dis. Res."},{"key":"24184_CR2","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41572-020-0210-0","volume":"6","author":"A Bardhan","year":"2020","unstructured":"Bardhan, A. et al. Epidermolysis bullosa. Nat. Rev. Dis. Primers 6, 78. https:\/\/doi.org\/10.1038\/s41572-020-0210-0 (2020).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"24184_CR3","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.18921","author":"C Has","year":"2020","unstructured":"Has, C. et al. Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility. Br. J. Dermatol. https:\/\/doi.org\/10.1111\/bjd.18921 (2020).","journal-title":"Br. J. Dermatol."},{"key":"24184_CR4","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s40257-021-00626-3","volume":"22","author":"PC Hou","year":"2021","unstructured":"Hou, P. C. et al. Investigational treatments for epidermolysis bullosa. Am. J. Clin. Dermatol. 22, 801\u2013817. https:\/\/doi.org\/10.1007\/s40257-021-00626-3 (2021).","journal-title":"Am. J. Clin. Dermatol."},{"issue":"Suppl 1","key":"24184_CR5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10198-016-0783-4","volume":"17","author":"A Angelis","year":"2016","unstructured":"Angelis, A. et al. Social\/economic costs and health-related quality of life in patients with epidermolysis bullosa in Europe. Eur. J. Health Econ. 17(Suppl 1), 31\u201342. https:\/\/doi.org\/10.1007\/s10198-016-0783-4 (2016).","journal-title":"Eur. J. Health Econ."},{"key":"24184_CR6","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/s41591-022-01737-y","volume":"28","author":"I Gurevich","year":"2022","unstructured":"Gurevich, I. et al. In vivo topical gene therapy for recessive dystrophic epidermolysis bullosa: A phase 1 and 2 trial. Nat. Med. 28, 780\u2013788. https:\/\/doi.org\/10.1038\/s41591-022-01737-y (2022).","journal-title":"Nat. Med."},{"key":"24184_CR7","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.ymthe.2019.03.007","volume":"27","author":"J Bonafont","year":"2019","unstructured":"Bonafont, J. et al. Clinically relevant correction of recessive dystrophic epidermolysis bullosa by dual sgRNA CRISPR\/Cas9-mediated gene editing. Mol. Ther. 27, 986\u2013998. https:\/\/doi.org\/10.1016\/j.ymthe.2019.03.007 (2019).","journal-title":"Mol. Ther."},{"key":"24184_CR8","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1038\/s41596-020-00450-9","volume":"16","author":"TP Huang","year":"2021","unstructured":"Huang, T. P., Newby, G. A. & Liu, D. R. Precision genome editing using cytosine and adenine base editors in mammalian cells. Nat. Protoc. 16, 1089\u20131128. https:\/\/doi.org\/10.1038\/s41596-020-00450-9 (2021).","journal-title":"Nat. Protoc."},{"key":"24184_CR9","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/s41580-019-0131-5","volume":"20","author":"A Pickar-Oliver","year":"2019","unstructured":"Pickar-Oliver, A. & Gersbach, C. A. The next generation of CRISPR-Cas technologies and applications. Nat. Rev. Mol. Cell Biol. 20, 490\u2013507. https:\/\/doi.org\/10.1038\/s41580-019-0131-5 (2019).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"24184_CR10","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/s41587-020-0561-9","volume":"38","author":"AV Anzalone","year":"2020","unstructured":"Anzalone, A. V., Koblan, L. W. & Liu, D. R. Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors. Nat. Biotechnol. 38, 824\u2013844. https:\/\/doi.org\/10.1038\/s41587-020-0561-9 (2020).","journal-title":"Nat. Biotechnol."},{"key":"24184_CR11","doi-asserted-by":"publisher","first-page":"3107","DOI":"10.1016\/j.ymthe.2021.09.002","volume":"29","author":"GA Newby","year":"2021","unstructured":"Newby, G. A. & Liu, D. R. In vivo somatic cell base editing and prime editing. Mol. Ther. 29, 3107\u20133124. https:\/\/doi.org\/10.1016\/j.ymthe.2021.09.002 (2021).","journal-title":"Mol. Ther."},{"key":"24184_CR12","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/s41586-020-03086-7","volume":"589","author":"LW Koblan","year":"2021","unstructured":"Koblan, L. W. et al. In vivo base editing rescues Hutchinson\u2013Gilford progeria syndrome in mice. Nature 589, 608\u2013614. https:\/\/doi.org\/10.1038\/s41586-020-03086-7 (2021).","journal-title":"Nature"},{"key":"24184_CR13","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/nature24644","volume":"551","author":"NM Gaudelli","year":"2017","unstructured":"Gaudelli, N. M. et al. Programmable base editing of A*T to G*C in genomic DNA without DNA cleavage. Nature 551, 464\u2013471. https:\/\/doi.org\/10.1038\/nature24644 (2017).","journal-title":"Nature"},{"key":"24184_CR14","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1042\/ETLS20180148","volume":"3","author":"G Naso","year":"2019","unstructured":"Naso, G. & Petrova, A. CRISPR\/Cas9 gene editing for genodermatoses: Progress and perspectives. Emerg. Top. Life Sci. 3, 313\u2013326. https:\/\/doi.org\/10.1042\/ETLS20180148 (2019).","journal-title":"Emerg. Top. Life Sci."},{"key":"24184_CR15","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/ng1041","volume":"32","author":"M Chen","year":"2002","unstructured":"Chen, M. et al. Restoration of type VII collagen expression and function in dystrophic epidermolysis bullosa. Nat. Genet. 32, 670\u2013675. https:\/\/doi.org\/10.1038\/ng1041 (2002).","journal-title":"Nat. Genet."},{"key":"24184_CR16","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.jid.2019.07.701","volume":"140","author":"MJ Osborn","year":"2020","unstructured":"Osborn, M. J. et al. Base editor correction of COL7A1 in recessive dystrophic epidermolysis bullosa patient-derived fibroblasts and iPSCs. J. Investig. Dermatol. 140, 338\u2013347. https:\/\/doi.org\/10.1016\/j.jid.2019.07.701 (2020).","journal-title":"J. Investig. Dermatol."},{"key":"24184_CR17","doi-asserted-by":"publisher","first-page":"eaax5717","DOI":"10.1126\/sciadv.aax5717","volume":"5","author":"HA Rees","year":"2019","unstructured":"Rees, H. A., Wilson, C., Doman, J. L. & Liu, D. R. Analysis and minimization of cellular RNA editing by DNA adenine base editors. Sci. Adv. 5, eaax5717. https:\/\/doi.org\/10.1126\/sciadv.aax5717 (2019).","journal-title":"Sci. Adv."},{"key":"24184_CR18","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/s41587-020-0453-z","volume":"38","author":"MF Richter","year":"2020","unstructured":"Richter, M. F. et al. Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activity. Nat. Biotechnol. 38, 883\u2013891. https:\/\/doi.org\/10.1038\/s41587-020-0453-z (2020).","journal-title":"Nat. Biotechnol."},{"key":"24184_CR19","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1186\/s12859-018-2585-4","volume":"19","author":"GH Hwang","year":"2018","unstructured":"Hwang, G. H. et al. Web-based design and analysis tools for CRISPR base editing. BMC Bioinform. 19, 542. https:\/\/doi.org\/10.1186\/s12859-018-2585-4 (2018).","journal-title":"BMC Bioinform."},{"key":"24184_CR20","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1089\/crispr.2018.0014","volume":"1","author":"MG Kluesner","year":"2018","unstructured":"Kluesner, M. G. et al. EditR: A method to quantify base editing from sanger sequencing. CRISPR J. 1, 239\u2013250. https:\/\/doi.org\/10.1089\/crispr.2018.0014 (2018).","journal-title":"CRISPR J."},{"key":"24184_CR21","doi-asserted-by":"publisher","first-page":"W242","DOI":"10.1093\/nar\/gky354","volume":"46","author":"JP Concordet","year":"2018","unstructured":"Concordet, J. P. & Haeussler, M. CRISPOR: Intuitive guide selection for CRISPR\/Cas9 genome editing experiments and screens. Nucleic Acids Res. 46, W242\u2013W245. https:\/\/doi.org\/10.1093\/nar\/gky354 (2018).","journal-title":"Nucleic Acids Res."},{"key":"24184_CR22","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nbt.3437","volume":"34","author":"JG Doench","year":"2016","unstructured":"Doench, J. G. et al. Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9. Nat. Biotechnol. 34, 184\u2013191. https:\/\/doi.org\/10.1038\/nbt.3437 (2016).","journal-title":"Nat. Biotechnol."},{"key":"24184_CR23","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41576-018-0006-1","volume":"19","author":"E Eisenberg","year":"2018","unstructured":"Eisenberg, E. & Levanon, E. Y. A-to-I RNA editing: Immune protector and transcriptome diversifier. Nat. Rev. Genet. 19, 473\u2013490. https:\/\/doi.org\/10.1038\/s41576-018-0006-1 (2018).","journal-title":"Nat. Rev. Genet."},{"key":"24184_CR24","doi-asserted-by":"publisher","first-page":"W305","DOI":"10.1093\/nar\/gkp427","volume":"37","author":"J Chen","year":"2009","unstructured":"Chen, J., Bardes, E. E., Aronow, B. J. & Jegga, A. G. ToppGene suite for gene list enrichment analysis and candidate gene prioritization. Nucleic Acids Res. 37, W305-311. https:\/\/doi.org\/10.1093\/nar\/gkp427 (2009).","journal-title":"Nucleic Acids Res."},{"key":"24184_CR25","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.ymthe.2020.07.021","volume":"28","author":"YK Jeong","year":"2020","unstructured":"Jeong, Y. K., Song, B. & Bae, S. Current status and challenges of DNA base editing tools. Mol. Ther. 28, 1938\u20131952. https:\/\/doi.org\/10.1016\/j.ymthe.2020.07.021 (2020).","journal-title":"Mol. Ther."},{"key":"24184_CR26","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1907081116","author":"J Jackow","year":"2019","unstructured":"Jackow, J. et al. CRISPR\/Cas9-based targeted genome editing for correction of recessive dystrophic epidermolysis bullosa using iPS cells. Proc. Natl. Acad. Sci. USA https:\/\/doi.org\/10.1073\/pnas.1907081116 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"24184_CR27","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nature17946","volume":"533","author":"AC Komor","year":"2016","unstructured":"Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A. & Liu, D. R. Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature 533, 420\u2013424. https:\/\/doi.org\/10.1038\/nature17946 (2016).","journal-title":"Nature"},{"key":"24184_CR28","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.omtn.2018.06.008","volume":"12","author":"A Izmiryan","year":"2018","unstructured":"Izmiryan, A. et al. Ex vivo COL7A1 correction for recessive dystrophic epidermolysis bullosa using CRISPR\/Cas9 and homology-directed repair. Mol. Ther. Nucleic Acids 12, 554\u2013567. https:\/\/doi.org\/10.1016\/j.omtn.2018.06.008 (2018).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"24184_CR29","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","volume":"576","author":"AV Anzalone","year":"2019","unstructured":"Anzalone, A. V. et al. Search-and-replace genome editing without double-strand breaks or donor DNA. Nature 576, 149\u2013157. https:\/\/doi.org\/10.1038\/s41586-019-1711-4 (2019).","journal-title":"Nature"},{"key":"24184_CR30","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/s41586-019-1161-z","volume":"569","author":"J Grunewald","year":"2019","unstructured":"Grunewald, J. et al. Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors. Nature 569, 433\u2013437. https:\/\/doi.org\/10.1038\/s41586-019-1161-z (2019).","journal-title":"Nature"},{"key":"24184_CR31","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1111\/gtc.12870","volume":"26","author":"A Miyawaki-Kuwakado","year":"2021","unstructured":"Miyawaki-Kuwakado, A. et al. Transcriptome analysis of gene expression changes upon enzymatic dissociation in skeletal myoblasts. Genes Cells 26, 530\u2013540. https:\/\/doi.org\/10.1111\/gtc.12870 (2021).","journal-title":"Genes Cells"},{"key":"24184_CR32","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/s41587-020-0453-z","volume":"38","author":"MF Richter","year":"2020","unstructured":"Richter, M. F. et al. Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activity. Nat. Biotechnol. 38, 883\u2013891. https:\/\/doi.org\/10.1038\/s41587-020-0453-z (2020).","journal-title":"Nat. Biotechnol."},{"key":"24184_CR33","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/s41551-020-00632-6","volume":"5","author":"S Suh","year":"2021","unstructured":"Suh, S. et al. Restoration of visual function in adult mice with an inherited retinal disease via adenine base editing. Nat. Biomed. Eng. 5, 169\u2013178. https:\/\/doi.org\/10.1038\/s41551-020-00632-6 (2021).","journal-title":"Nat. Biomed. Eng."},{"key":"24184_CR34","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1038\/s41467-020-15892-8","volume":"11","author":"T Jiang","year":"2020","unstructured":"Jiang, T. et al. Chemical modifications of adenine base editor mRNA and guide RNA expand its application scope. Nat. Commun. 11, 1979. https:\/\/doi.org\/10.1038\/s41467-020-15892-8 (2020).","journal-title":"Nat. Commun."},{"key":"24184_CR35","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41586-021-03534-y","volume":"593","author":"K Musunuru","year":"2021","unstructured":"Musunuru, K. et al. In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates. Nature 593, 429\u2013434. https:\/\/doi.org\/10.1038\/s41586-021-03534-y (2021).","journal-title":"Nature"},{"key":"24184_CR36","doi-asserted-by":"publisher","first-page":"3727","DOI":"10.1021\/acs.biochem.9b00573","volume":"58","author":"S Park","year":"2019","unstructured":"Park, S. & Beal, P. A. Off-target editing by CRISPR-guided DNA base editors. Biochemistry 58, 3727\u20133734. https:\/\/doi.org\/10.1021\/acs.biochem.9b00573 (2019).","journal-title":"Biochemistry"},{"key":"24184_CR37","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1016\/j.ymthe.2022.07.010","volume":"30","author":"T Tu","year":"2022","unstructured":"Tu, T. et al. A precise and efficient adenine base editor. Mol. Ther. 30, 2933\u20132941. https:\/\/doi.org\/10.1016\/j.ymthe.2022.07.010 (2022).","journal-title":"Mol. Ther."},{"key":"24184_CR38","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1038\/s41587-021-00943-2","volume":"39","author":"YK Jeong","year":"2021","unstructured":"Jeong, Y. K. et al. Adenine base editor engineering reduces editing of bystander cytosines. Nat. Biotechnol. 39, 1426\u20131433. https:\/\/doi.org\/10.1038\/s41587-021-00943-2 (2021).","journal-title":"Nat. Biotechnol."},{"key":"24184_CR39","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.cell.2020.05.037","volume":"182","author":"M Arbab","year":"2020","unstructured":"Arbab, M. et al. Determinants of base editing outcomes from target library analysis and machine learning. Cell 182, 463\u2013480. https:\/\/doi.org\/10.1016\/j.cell.2020.05.037 (2020).","journal-title":"Cell"},{"key":"24184_CR40","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1038\/s41587-020-0573-5","volume":"38","author":"M Song","year":"2020","unstructured":"Song, M. et al. Sequence-specific prediction of the efficiencies of adenine and cytosine base editors. Nat. Biotechnol. 38, 1037\u20131043. https:\/\/doi.org\/10.1038\/s41587-020-0573-5 (2020).","journal-title":"Nat. Biotechnol."},{"key":"24184_CR41","doi-asserted-by":"publisher","first-page":"5114","DOI":"10.1038\/s41467-021-25375-z","volume":"12","author":"KF Marquart","year":"2021","unstructured":"Marquart, K. F. et al. Predicting base editing outcomes with an attention-based deep learning algorithm trained on high-throughput target library screens. Nat. Commun. 12, 5114. https:\/\/doi.org\/10.1038\/s41467-021-25375-z (2021).","journal-title":"Nat. Commun."},{"key":"24184_CR42","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1038\/s41467-021-22519-z","volume":"12","author":"J Li","year":"2021","unstructured":"Li, J. et al. Structure-guided engineering of adenine base editor with minimized RNA off-targeting activity. Nat. Commun. 12, 2287. https:\/\/doi.org\/10.1038\/s41467-021-22519-z (2021).","journal-title":"Nat. Commun."},{"key":"24184_CR43","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41586-019-1314-0","volume":"571","author":"C Zhou","year":"2019","unstructured":"Zhou, C. et al. Off-target RNA mutation induced by DNA base editing and its elimination by mutagenesis. Nature 571, 275\u2013278. https:\/\/doi.org\/10.1038\/s41586-019-1314-0 (2019).","journal-title":"Nature"},{"key":"24184_CR44","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1038\/s41587-020-0491-6","volume":"38","author":"NM Gaudelli","year":"2020","unstructured":"Gaudelli, N. M. et al. Directed evolution of adenine base editors with increased activity and therapeutic application. Nat. Biotechnol. 38, 892\u2013900. https:\/\/doi.org\/10.1038\/s41587-020-0491-6 (2020).","journal-title":"Nat. Biotechnol."},{"key":"24184_CR45","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1101\/gr.199588.115","volume":"26","author":"D Kim","year":"2016","unstructured":"Kim, D., Kim, S., Kim, S., Park, J. & Kim, J. S. Genome-wide target specificities of CRISPR-Cas9 nucleases revealed by multiplex Digenome-seq. Genome Res. 26, 406\u2013415. https:\/\/doi.org\/10.1101\/gr.199588.115 (2016).","journal-title":"Genome Res."},{"key":"24184_CR46","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1146\/annurev-biochem-013118-111730","volume":"88","author":"D Kim","year":"2019","unstructured":"Kim, D., Luk, K., Wolfe, S. A. & Kim, J. S. Evaluating and enhancing target specificity of gene-editing nucleases and deaminases. Annu. Rev. Biochem. 88, 191\u2013220. https:\/\/doi.org\/10.1146\/annurev-biochem-013118-111730 (2019).","journal-title":"Annu. Rev. Biochem."},{"key":"24184_CR47","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.jconrel.2010.10.020","volume":"150","author":"G Tavernier","year":"2011","unstructured":"Tavernier, G. et al. mRNA as gene therapeutic: How to control protein expression. J. Control Release 150, 238\u2013247. https:\/\/doi.org\/10.1016\/j.jconrel.2010.10.020 (2011).","journal-title":"J. Control Release"},{"key":"24184_CR48","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.nano.2013.11.008","volume":"10","author":"C Leonhardt","year":"2014","unstructured":"Leonhardt, C. et al. Single-cell mRNA transfection studies: Delivery, kinetics and statistics by numbers. Nanomedicine 10, 679\u2013688. https:\/\/doi.org\/10.1016\/j.nano.2013.11.008 (2014).","journal-title":"Nanomedicine"},{"key":"24184_CR49","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.addr.2020.10.014","volume":"168","author":"Q Chen","year":"2021","unstructured":"Chen, Q., Zhang, Y. & Yin, H. Recent advances in chemical modifications of guide RNA, mRNA and donor template for CRISPR-mediated genome editing. Adv. Drug Deliv. Rev. 168, 246\u2013258. https:\/\/doi.org\/10.1016\/j.addr.2020.10.014 (2021).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"24184_CR50","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1038\/s41467-020-15892-8","volume":"11","author":"T Jiang","year":"2020","unstructured":"Jiang, T. et al. Chemical modifications of adenine base editor mRNA and guide RNA expand its application scope. Nat. Commun. 11, 1979. https:\/\/doi.org\/10.1038\/s41467-020-15892-8 (2020).","journal-title":"Nat. Commun."},{"key":"24184_CR51","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","volume":"384","author":"LR Baden","year":"2021","unstructured":"Baden, L. R. et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N. Engl. J. Med. 384, 403\u2013416. https:\/\/doi.org\/10.1056\/NEJMoa2035389 (2021).","journal-title":"N. Engl. J. Med."},{"key":"24184_CR52","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1056\/NEJMoa2028436","volume":"383","author":"EJ Anderson","year":"2020","unstructured":"Anderson, E. J. et al. Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults. N. Engl. J. Med. 383, 2427\u20132438. https:\/\/doi.org\/10.1056\/NEJMoa2028436 (2020).","journal-title":"N. Engl. J. Med."},{"key":"24184_CR53","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.jconrel.2012.12.029","volume":"166","author":"KK Phua","year":"2013","unstructured":"Phua, K. K., Leong, K. W. & Nair, S. K. Transfection efficiency and transgene expression kinetics of mRNA delivered in naked and nanoparticle format. J. Control Release 166, 227\u2013233. https:\/\/doi.org\/10.1016\/j.jconrel.2012.12.029 (2013).","journal-title":"J. Control Release"},{"key":"24184_CR54","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3390\/pharmaceutics12020092","volume":"12","author":"J Dorrie","year":"2020","unstructured":"Dorrie, J., Schaft, N., Schuler, G. & Schuler-Thurner, B. Therapeutic cancer vaccination with ex vivo RNA-transfected dendritic cells-an update. Pharmaceutics 12, 92. https:\/\/doi.org\/10.3390\/pharmaceutics12020092 (2020).","journal-title":"Pharmaceutics"},{"key":"24184_CR55","doi-asserted-by":"publisher","first-page":"5167","DOI":"10.1021\/acs.nanolett.0c00596","volume":"20","author":"KA Hajj","year":"2020","unstructured":"Hajj, K. A. et al. A potent branched-tail lipid nanoparticle enables multiplexed mRNA delivery and gene editing in vivo. Nano Lett. 20, 5167\u20135175. https:\/\/doi.org\/10.1021\/acs.nanolett.0c00596 (2020).","journal-title":"Nano Lett."},{"key":"24184_CR56","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357\u2013359. https:\/\/doi.org\/10.1038\/nmeth.1923 (2012).","journal-title":"Nat. Methods"},{"key":"24184_CR57","doi-asserted-by":"publisher","first-page":"giab008","DOI":"10.1093\/gigascience\/giab008","volume":"10","author":"P Danecek","year":"2021","unstructured":"Danecek, P. et al. Twelve years of SAMtools and BCFtools. Gigascience 10, giab008. https:\/\/doi.org\/10.1093\/gigascience\/giab008 (2021).","journal-title":"Gigascience"},{"key":"24184_CR58","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/s41587-019-0201-4","volume":"37","author":"D Kim","year":"2019","unstructured":"Kim, D., Paggi, J. M., Park, C., Bennett, C. & Salzberg, S. L. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat. Biotechnol. 37, 907\u2013915. https:\/\/doi.org\/10.1038\/s41587-019-0201-4 (2019).","journal-title":"Nat. Biotechnol."},{"key":"24184_CR59","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.21105\/joss.03021","volume":"6","author":"ML Waskom","year":"2021","unstructured":"Waskom, M. L. Seaborn: Statistical data visualization. J. Open Source Softw. 6, 3021. https:\/\/doi.org\/10.21105\/joss.03021 (2021).","journal-title":"J. Open Source Softw."},{"issue":"Suppl 1","key":"24184_CR60","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1093\/bioinformatics\/17.suppl_1.s22","volume":"17","author":"Z Bar-Joseph","year":"2001","unstructured":"Bar-Joseph, Z., Gifford, D. K. & Jaakkola, T. S. Fast optimal leaf ordering for hierarchical clustering. Bioinformatics 17(Suppl 1), S22-29. https:\/\/doi.org\/10.1093\/bioinformatics\/17.suppl_1.s22 (2001).","journal-title":"Bioinformatics"},{"key":"24184_CR61","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41592-019-0686-2","volume":"17","author":"P Virtanen","year":"2020","unstructured":"Virtanen, P. et al. SciPy 1.0: Fundamental algorithms for scientific computing in Python. Nat. Methods 17, 261\u2013272. https:\/\/doi.org\/10.1038\/s41592-019-0686-2 (2020).","journal-title":"Nat. Methods"},{"key":"24184_CR62","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1093\/bioinformatics\/btt287","volume":"29","author":"E Picardi","year":"2013","unstructured":"Picardi, E. & Pesole, G. REDItools: High-throughput RNA editing detection made easy. Bioinformatics 29, 1813\u20131814. https:\/\/doi.org\/10.1093\/bioinformatics\/btt287 (2013).","journal-title":"Bioinformatics"},{"key":"24184_CR63","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671\u2013675. https:\/\/doi.org\/10.1038\/nmeth.2089 (2012).","journal-title":"Nat. Methods"},{"key":"24184_CR64","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1242\/jcs.042895","volume":"122","author":"VL Martins","year":"2009","unstructured":"Martins, V. L. et al. Increased invasive behaviour in cutaneous squamous cell carcinoma with loss of basement-membrane type VII collagen. J. Cell Sci. 122, 1788\u20131799. https:\/\/doi.org\/10.1242\/jcs.042895 (2009).","journal-title":"J. Cell Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-24184-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-24184-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-24184-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T06:13:02Z","timestamp":1668579182000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-24184-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,16]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["24184"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-24184-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,16]]},"assertion":[{"value":"1 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare competing financial interests: D.R.L. is a consultant and equity holder of Prime Medicine, Beam Therapeutics, Pairwise Plants, Chroma Medicine, and Nvelop Therapeutics, companies that use or deliver gene editing or genome engineering agents. Harvard University and the Broad Institute have filed patent applications on base editing technologies. There are no other competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19643"}}